![Is Organogenesis a Hidden Gem in the Biotech Sector?](https://stocknews.com/wp-content/uploads/2022/03/shutterstock_517925923-scaled.jpg)
Leading wound care specialist Organogenesis Holdings Inc. (ORGO) surpassed Wall Street’s expectations in the first quarter of fiscal 2024. The company reported revenue of $109.98 million, well above the analysts’ estimate of $100.23 million. This figure also outpaced their guidance, which projected revenue between $98 million and $104 million, driven by a surge in momentum from February into March.
Building on the momentum, Organogenesis forecasts positive growth for the year ending…
Read More…